ArticleThe oncologist2021

Tyrosine Kinase Inhibitors and Vascular Adverse Events in Patients with Chronic Myeloid Leukemia: A Population-Based, Propensity Score-Matched Cohort Study.

Mei-Tsen Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.